CRC EVs had a variety of different effects on other CAF markers (e.g., PDGFRβ or periostin), suggesting that they may play a role in the formation of different (non‐myofibroblastic) CAF subtypes in tumour stroma. The gene discussed is PDGFRB; the disease is neoplasm.